Choroid Plexus Carcinoma
Last Posted: Mar 10, 2023
- Revisiting tumor patterns and penetrance in germline TP53 mutation carriers: temporal phases of Li-Fraumeni syndrome.
Amadou Amina, et al. Current opinion in oncology 2017 0 (1) 23-29
- DNA methylation signature is prognostic of choroid plexus tumor aggressiveness.
Pienkowska Malgorzata, et al. Clinical epigenetics 2019 0 (1) 117
- Moderate-to-strong expression of FGFR3 and TP53 alterations in a subpopulation of choroid plexus tumors.
Granberg Kirsi J, et al. Histology and histopathology 2019 0 (7) 673-680
- Clinical spectrum of Li-Fraumeni syndrome/Li-Fraumeni-like syndrome in Brazilian individuals with the TP53 p.R337H mutation.
Ferreira Amanda Meneses, et al. The Journal of steroid biochemistry and molecular biology 2019 0 250-255
- Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy.
Kline Cassie N et al. Neuro-oncology 2017 19(5) 699-709
- Occurrence of Neuroblastoma among TP53 p.R337H Carriers.
Seidinger Ana Luiza, et al. PloS one 2015 0 (10) e0140356
- Alternative lengthening of telomeres is enriched in, and impacts survival of TP53 mutant pediatric malignant brain tumors.
Mangerel Joshua, et al. Acta neuropathologica 2014 12 (6) 853-62
- Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil.
Giacomazzi Juliana, et al. Cancer 2013 12 (24) 4341-9
- Impact of neonatal screening and surveillance for the TP53 R337H mutation on early detection of childhood adrenocortical tumors.
Custódio Gislaine, et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013 7 (20) 2619-26
- Increased incidence of choroid plexus carcinoma due to the germline TP53 R337H mutation in southern Brazil.
Custodio Gislaine, et al. PloS one 2011 0 (3) e18015
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Graves Disease
- Huntington Disease
- Myasthenia Gravis
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2023
- Page last updated:Jun 02, 2023
- Content source: